BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261105T120000
DTEND;TZID=America/New_York:20261105T130000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Emerging Threats in the Illicit Drug Supply: Understanding Medetomidine
DESCRIPTION:This webinar will provide healthcare professionals with an evidence-based overview of medetomidine\, an emerging nonopioid adulterant increasingly identified in the illicit fentanyl supply. Participants will be able to recognize the clinical features of medetomidine-associated intoxication and withdrawal\, differentiate these presentations from other withdrawal symptoms\, and apply appropriate evaluation and management strategies. Early recognition\, limitations of routine toxicology testing\, and strategies to reduce risk and support harm reduction for people who use drugs that may be exposed to medetomidine-contaminated substances will also be discussed. This program is being provided in partnership with Wilson County Substance Prevention Coalition (via HRSA RCORP Impact Grant). The Health Resources and Services Administration (HRSA)\, Department of Health and Human Services (HHS) provided financial support for this program. The award provided 100% of total costs and totaled $825\,514. The contents are those of the author. They may not reflect the policies of HRSA\, HHS\, or the U.S. Government.\nhttps://www.arealahec.org/courses-and-events/79063/emerging-threats-in-the-illicit-drug-supply-understanding-medetomidine
X-ALT-DESC;FMTTYPE=text/html:This webinar will provide healthcare professionals with an evidence-based overview of medetomidine\, an emerging nonopioid adulterant increasingly identified in the illicit fentanyl supply. Participants will be able to recognize the clinical features of medetomidine-associated intoxication and withdrawal\, differentiate these presentations from other withdrawal symptoms\, and apply appropriate evaluation and management strategies. Early recognition\, limitations of routine toxicology testing\, and strategies to reduce risk and support harm reduction for people who use drugs that may be exposed to medetomidine-contaminated substances will also be discussed. This program is being provided in partnership with Wilson County Substance Prevention Coalition (via HRSA RCORP Impact Grant). The Health Resources and Services Administration (HRSA)\, Department of Health and Human Services (HHS) provided financial support for this program. The award provided 100% of total costs and totaled $825\,514. The contents are those of the author. They may not reflect the policies of HRSA\, HHS\, or the U.S. Government.
https://www.arealahec.org/courses-and-events/79063/emerging-threats-in-the-illicit-drug-supply-understanding-medetomidine
LOCATION:
UID:e.3936.1620188
SEQUENCE:3
DTSTAMP:20260917T133350Z
URL:https://business.rockymountchamber.org/community-calendar/Details/emerging-threats-in-the-illicit-drug-supply-understanding-medetomidine-1905079?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR